Physician

Kleesy L Thomas, MD

According to 2025 Medicare claims, Kleesy Thomas, MD (NPI: 1487032462) practices dermatology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is ABILENE DERMATOLOGY AND SKIN SURGERY CENTER PC (NPI: 1962681304; TIN: 208636268) and primary practice location at 79606-5006.

Thomas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,367 traditional Medicare patients, billed 8,033 HCPCS/CPT codes, and received $691,931 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,501 prescription claims across 483 beneficiaries totaling $875,423 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 45 records totaling $847. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $183,960 to $691,931. Similarly, Part D prescription costs have risen steadily, from $4,524 to $875,423. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$346K$692K2019 Medicare payment: $183,960 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $331,355 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $525,604 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $460,098 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $520,750 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $691,931 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195242,022$183,960
20208093,798$331,355
20219355,558$525,604
20229615,414$460,098
20239596,474$520,750
20241,3678,033$691,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$438K$875K2015 Drug cost: $4,524 (USD; Tot_Drug_Cst)2016 Drug cost: $15,353 (USD; Tot_Drug_Cst)2017 Drug cost: $17,011 (USD; Tot_Drug_Cst)2018 Drug cost: $12,709 (USD; Tot_Drug_Cst)2019 Drug cost: $259,751 (USD; Tot_Drug_Cst)2020 Drug cost: $284,642 (USD; Tot_Drug_Cst)2021 Drug cost: $567,630 (USD; Tot_Drug_Cst)2022 Drug cost: $775,453 (USD; Tot_Drug_Cst)2023 Drug cost: $811,725 (USD; Tot_Drug_Cst)2024 Drug cost: $875,423 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151884$4,524
201676220$15,353
2017147309$17,011
2018123272$12,709
2019250568$259,751
20203421,017$284,642
20213941,169$567,630
20224021,114$775,453
20234351,332$811,725
20244831,501$875,423

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths364423$81
88331Pathology examination of specimen during surgery, first tissue block448704$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more681899$63
17000Destruction of precancer skin growth, 1 growth480590$34
17003Destruction of precancer skin growth, 2-14 growths3842,317$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab641,764$240,146
Humira(Cf) PenAdalimumab16448$197,931
Taltz AutoinjectorIxekizumab11308$74,853
Clobetasol PropionateClobetasol Propionate2797,079$11,652
Mycophenolate MofetilMycophenolate Mofetil291,440$6,423

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$847ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kleesy L. Thomas, MD?

Tedicare shows public-source Medicare data for Kleesy L. Thomas, MD (NPI 1487032462), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kleesy L. Thomas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kleesy L. Thomas, MD?

Kleesy L. Thomas, MD is linked to ABILENE DERMATOLOGY AND SKIN SURGERY CENTER PC (billing NPI 1962681304) in the available physician profile data.

Does Kleesy L. Thomas, MD have Open Payments data?

Kleesy L. Thomas, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.